WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Nov 6, 2015
Insider Transaction Report
Form 4
ANDERSON MICHAEL A
Vice President & Treasurer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2015-11-05$22.48/sh−10,000$224,800→ 1,414 totalExercise: $22.48From: 2008-02-27Exp: 2018-02-27→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2015-11-05$22.48/sh+10,000$224,850→ 74,497.02 total - Sale
Common Stock
2015-11-05$61.98/sh−10,000$619,817→ 64,497.02 total
Holdings
- 7,333.41(indirect: Non-Qualified Deferred Compensation Plan)
Common Stock
- 911.894(indirect: By Savings Plan)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $61.97 to $62.02, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.